Elucidating the Rickettsia prowazekii EnvZ/OmpR Regulon

阐明普瓦泽基立克次体 EnvZ/OmpR 调节子

基本信息

  • 批准号:
    7286854
  • 负责人:
  • 金额:
    $ 17.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-09-15 至 2009-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Members of the genus Rickettsia are obligate intracytoplasmic pathogens that cause diseases such as epidemic and endemic typhus in humans. It is estimated that R. prowazekii, the louse-vectored agent of epidemic typhus, has caused more than 3 million deaths in the last century! R. prowazekii is a Select Agent and has been designated by the NIAID as a Category B Priority Pathogen. In vivo, rickettsiae are confined to a limited number of environmental niches that include transitioning between growth in gut epithelial cell of the louse vector to the blood stream of the human host and to the human endothelial cell. Considering the paucity of organisms that have successfully adapted to growth in eukaryotic cytosol as a growth niche, cytosol could be thought of as a hostile environment. In addition, due to the nature of this obligate intracellular life style, any time spent outside of a host cell under non-growing conditions is a potential stress condition indicating that the ability to communicate with the environment is likely critical to R. prowazekii pathogenesis. This R21 proposal will lay the foundation from which these extremely interesting questions can be further explored. Based on the prominent role of two-component response regulators in sensing environmental changes, I have selected the R. prowazekii ORFs RP426/RP427 (annotated as EnvZ/OmpR) as a potential sensor kinase/response regulator pair and will elucidate the regulon of genes under their control. The goal of this R21 proposal is to use this two-component network as a relevant biological model to adapt the Chromatin Immunoprecipitation (ChIP) technique for use on an obligate intracellular, cytosol-limited pathogen. The Specific Aim describes two approaches. I will use purified, recombinant OmpR, phosphorylated OmpR (OmpR approximately P) and R. prowazekii chromosomal DNA fragments to perform an in vitro ChIP assay. OmpR/OmpR approximately P-bound regulatory sequences will be isolated, cloned, and identified by DNA sequencing. This in vitro approach will identify regulatory sequences independent of environmental conditions. The second approach is an in vivo ChIP assay that will isolate regulatory DNA sequences from R. prowazekii grown under controlled environmental conditions. The conditions will be selected based on the data generated by the in vitro ChIP and also based on the limited number of environmental niches to which rickettsiae are exposed. The combination of these two techniques will elucidate R. prowazekii genes controlled by OmpR and could provide insight into the environmental stimuli to which this system responds. Consistent with the exploratory/development nature of an R21 application, this study represents the first effort to develop chromatin immunoprecipitation to elucidate a gene regulon in an obligate, intracellular pathogen using R. prowazekii as the model system. Understanding the role of gene regulation in pathogenesis may be critical to developing countermeasures and novel therapies against obligate intracellular Select Agents.
描述(由申请人提供):立克次体属成员是专性胞质内病原体,可引起人类流行性和地方性斑疹伤寒等疾病。估计R.在上个世纪,传染性斑疹伤寒的虱媒prowazekii已经造成了300多万人死亡!R. prowazekii是一种选择性病原体,已被NIAID指定为B类优先病原体。在体内,立克次体局限于有限数量的环境小生境,包括在虱载体的肠上皮细胞中生长到人类宿主的血流和人类内皮细胞之间的转变。考虑到已经成功地适应在真核细胞质中生长的生物体的缺乏,细胞质可以被认为是一个敌对的环境。此外,由于这种专性细胞内生活方式的性质,在非生长条件下在宿主细胞外度过的任何时间都是潜在的应激条件,表明与环境交流的能力可能对R至关重要。prowazekii发病机制。这一R21建议将为进一步探讨这些极其有趣的问题奠定基础。基于双组分响应调节因子在感知环境变化中的突出作用,我选择了R。prowazekii ORF RP 426/RP 427(注释为EnvZ/OmpR)作为潜在的传感器激酶/反应调节子对,并将阐明在其控制下的基因的调节子。这个R21提案的目标是使用这种双组分网络作为相关的生物模型,以适应染色质免疫沉淀(ChIP)技术用于专性细胞内,胞质限制性病原体。具体目标描述了两种方法。我将使用纯化的重组OmpR、磷酸化OmpR(OmpR约为P)和R。prowazekii染色体DNA片段进行体外ChIP测定。将通过DNA测序分离、克隆和鉴定OmpR/OmpR近似P结合的调控序列。这种体外方法将识别不受环境条件影响的调节序列。第二种方法是体内ChIP测定,其将从R.在受控环境条件下生长的prowazekii。将根据体外ChIP生成的数据以及立克次体暴露的有限数量的环境小生境选择条件。这两种技术的结合将阐明R. prowazekii基因由OmpR控制,可以提供对该系统响应的环境刺激的洞察。与R21应用的探索性/开发性质一致,本研究代表了使用R. prowazekii作为模型系统。了解基因调控在发病机制中的作用可能对开发针对专性细胞内选择剂的对策和新疗法至关重要。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHON PETER AUDIA其他文献

JONATHON PETER AUDIA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHON PETER AUDIA', 18)}}的其他基金

The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
  • 批准号:
    10575258
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
Caspase-1, the Microvascular Endothelium, and Infection
Caspase-1、微血管内皮和感染
  • 批准号:
    9043174
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Caspase-1, the Microvascular Endothelium, and Infection
Caspase-1、微血管内皮和感染
  • 批准号:
    9402860
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Caspase-1, the Microvascular Endothelium, and Infection
Caspase-1、微血管内皮和感染
  • 批准号:
    9249628
  • 财政年份:
    2015
  • 资助金额:
    $ 17.83万
  • 项目类别:
Elucidating the Role of Phospholipase in the Epidemic Typhus Rickettsia
阐明磷脂酶在流行性斑疹伤寒立克次体中的作用
  • 批准号:
    8145106
  • 财政年份:
    2010
  • 资助金额:
    $ 17.83万
  • 项目类别:
Permeability of the Epidemic Typhus Rickettsia
流行性斑疹伤寒立克次体的渗透性
  • 批准号:
    8053160
  • 财政年份:
    2010
  • 资助金额:
    $ 17.83万
  • 项目类别:
Identification of Metabolic Virulence Factors in the Epidemic Typhus Rickettsia
流行性斑疹伤寒立克次体代谢毒力因子的鉴定
  • 批准号:
    7460821
  • 财政年份:
    2007
  • 资助金额:
    $ 17.83万
  • 项目类别:
Identification of Metabolic Virulence Factors in the Epidemic Typhus Rickettsia
流行性斑疹伤寒立克次体代谢毒力因子的鉴定
  • 批准号:
    7305296
  • 财政年份:
    2007
  • 资助金额:
    $ 17.83万
  • 项目类别:
Elucidating the Rickettsia prowazekii EnvZ/OmpR Regulon
阐明普瓦泽基立克次体 EnvZ/OmpR 调节子
  • 批准号:
    7048132
  • 财政年份:
    2006
  • 资助金额:
    $ 17.83万
  • 项目类别:
Permeability of the Epidemic Typhus Rickettsia
流行性斑疹伤寒立克次体的渗透性
  • 批准号:
    7570077
  • 财政年份:
    1979
  • 资助金额:
    $ 17.83万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 17.83万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
  • 批准号:
    10639161
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
  • 批准号:
    10752441
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
  • 批准号:
    10867639
  • 财政年份:
    2023
  • 资助金额:
    $ 17.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了